video-placeholder-01.png
test-placeholder-02.png
Medication Detail
CINQAIR - Teva Pharmaceutical Industries Limited Trademark Registration
Product Monograph Template - Schedule D]
Flopped trials dash Teva's hopes of battling GSK, AZ with subcutaneous Cinqair | Fierce Pharma
New Drug Product: Cinqair - MPR
Clinical Efficacy Guidelines
CINQAIR® (reslizumab) Injection – About Asthma Control
including co-pays, co-insurance, and deductibles.*
Reslizumab | New Drug Approvals
hcp.cinqair.com
Subcutaneous Cinqair results add to Teva's troubles
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
A program supporting CINQAIR® (reslizumab) Injection patients
Administering CINQAIR.
Cinqair (Reslizumab) 100mg/10mL Injection – Apothera
CINQAIR® (reslizumab) Injection – About Asthma Control
Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients
Attachment: Product Information: Reslizumab
CINQAIR® (reslizumab) Injection - Savings and Support
761033Orig1s000
CINQAIR® (reslizumab) Injection – About Asthma Control
Israeli Pharma gets FDA Approval for Asthma Antibody
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
Cinqair Prices, Coupons & Savings Tips - GoodRx
